Interactions of adrenergic blocking drugs with the in vivo release of thyroid hormone induced by thyrotrophin and the long-acting thyroid stimulator.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D005260:Female; D007456:Iodine Isotopes / Q000097:blood; D007545:Isoproterenol / Q000037:antagonists & inhibitors*; D008135:Long-Acting Thyroid Stimulator / Q000037:antagonists & inhibitors*; D051379:Mice; D010643:Phenoxybenzamine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D013961:Thyroid Gland / Q000187:drug effects; D013963:Thyroid Hormones / Q000378:metabolism; D013972:Thyrotropin / Q000037:antagonists & inhibitors*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D007456:Iodine Isotopes; D013963:Thyroid Hormones; D010643:Phenoxybenzamine; D013972:Thyrotropin; D008135:Long-Acting Thyroid Stimulator; D011433:Propranolol; D007545:Isoproterenol; D010646:Phentolamine